News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
BIZZARI JEAN-PIERRE
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/24/2023 |
4
| BIZZARI JEAN-PIERRE (Director) has filed a Form 4 on Aprea Therapeutics, Inc.|
Txns:
| Granted 12,500 options to buy
@ $3.65, valued at
$45.6k
|
|
| 05/09/2023 |
4
| BIZZARI JEAN-PIERRE (Director) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.|
Txns:
| Granted 8,065 shares
@ $0
Granted 11,371 options to buy
@ $31, valued at
$352.5k
|
|
| 05/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/01/2020 |
4
| BIZZARI JEAN-PIERRE (Director) has filed a Form 4 on HALOZYME THERAPEUTICS, INC.|
Txns:
| Granted 8,829 shares
@ $0 |
|
| 01/28/2020 |
4
| BIZZARI JEAN-PIERRE (Director) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC.|
Txns:
| Granted 20,000 options to buy
@ $3.23, valued at
$64.6k
|
|
| 05/03/2019 |
4
| BIZZARI JEAN-PIERRE (Director) has filed a Form 4 on HALOZYME THERAPEUTICS INC|
Txns:
| Granted 12,173 shares
@ $0 |
|
| 01/29/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/02/2018 |
4
| BIZZARI JEAN-PIERRE (Director) has filed a Form 4 on HALOZYME THERAPEUTICS INC|
Txns:
| Granted 10,363 shares
@ $0 |
|
| 05/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/30/2017 |
4
| BIZZARI JEAN-PIERRE (Director) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC.|
Txns:
| Granted 20,000 options to buy
@ $2.01, valued at
$40.2k
|
|
| 07/12/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/06/2016 |
4
| BIZZARI JEAN-PIERRE (Director) has filed a Form 4 on HALOZYME THERAPEUTICS INC|
Txns:
| Granted 20,202 shares
@ $0 |
|
| 02/18/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|